Clinical Trials Browser

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT07483060 2026-03-19

NG-ST

Phase 4 Not yet recruiting

90 enrolled

Gastrointestinal

Rectal Neoplasms

NCT07474961 2026-03-16

BLOOD-dose

Phase 4 Not yet recruiting

400 enrolled

LymphoidPlasma cell

Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT07257484 2026-03-13

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Phase 4 Not yet recruiting

30 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT07469202 2026-03-13

CYTALUX Dose Extension Study

Phase 4 Not yet recruiting

106 enrolled

GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms

NCT07469488 2026-03-13

AmiCARE

Phase 4 Not yet recruiting

122 enrolled

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

NCT07467174 2026-03-12

REPROG-RCT

Phase 4 Not yet recruiting

538 enrolled

Gastrointestinal

Stomach Neoplasms

NCT07459543 2026-03-09

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

Phase 4 Not yet recruiting

30 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT07446465 2026-03-03

FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer

Phase 4 Not yet recruiting

42 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT07436663 2026-02-27

SGLT2i/DPPi

Phase 4 Not yet recruiting

150 enrolled

Breast

Breast Neoplasms

NCT07278362 2026-02-23

Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance

Phase 4 Not yet recruiting

35 enrolled

Genitourinary

Eunuchism, Prostatic Neoplasms

NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Phase 4 Not yet recruiting

80 enrolled

DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Phase 4 Not yet recruiting

25 enrolled

Gynecologic

Endometrial Neoplasms

NCT07412873 2026-02-17

PROVIDENCE

Phase 4 Not yet recruiting

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07167862 2026-01-23

PPPOCUS

Phase 4 Not yet recruiting

96 enrolled

Lymphoid

Lymphoma, Follicular, Pre-Eclampsia

NCT07357597 2026-01-22

TROPION-SWISH

Phase 4 Not yet recruiting

100 enrolled

Stomatitis

NCT07358520 2026-01-22

Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients

Phase 4 Not yet recruiting

40 enrolled

Proteinuria

NCT07358975 2026-01-22

Prediction of Complications in Hepatic Tumors

Phase 4 Not yet recruiting

192 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT06786429 2026-01-21

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Phase 4 Not yet recruiting

1,800 enrolled

GastrointestinalGynecologic

Anxiety Disorders, Uterine Cervical Neoplasms, Depression, Hepatitis B, Carcinoma, Hepatocellular, Gallstones

NCT07354698 2026-01-21

MHI

Phase 4 Not yet recruiting

114 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT07344974 2026-01-20

Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity

Phase 4 Not yet recruiting

78 enrolled

Breast

Breast Neoplasms

Clinical Trials

PRECISE AM

DOSABEMA

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma

CervALONE

ESUS-ESD

A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer

REVIVE

NG-ST

BLOOD-dose

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

CYTALUX Dose Extension Study

AmiCARE

REPROG-RCT

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer

SGLT2i/DPPi

Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

PROVIDENCE

PPPOCUS

TROPION-SWISH

Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients

Prediction of Complications in Hepatic Tumors

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

MHI

Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity